Inventor · disambiguated record
Marat Alimzhanov
Also filed as: ALIMZHANOV MARAT · ALIMZHANOV MARAT B
5 granted patents·4 pending applications·510 citations·filing 2010–2022
82Inventor score
Top patents by PatentIndex Score
9 records- 0195US9493565B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2014·Granted Nov 15, 2016·50 cites·8 claims
- 0295US8779108B2Targeted binding agents against B7-H1QUEVA CHRISTOPHE·Filed 2010·Granted Jul 15, 2014·452 cites·31 claims
- 0390US10400039B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2016·Granted Sep 3, 2019·8 cites·8 claims
- 0480US2023235062A1Targeted binding agents against b7-h1MEDIMMUNE LTD·Filed 2022·Application pending·0 cites
- 0567US11518809B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2019·Granted Dec 6, 2022·0 cites·11 claims
- 0652US12227577B2Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for the treatment of cancerMERCK PATENT GMBH·Filed 2019·Granted Feb 18, 2025·0 cites·10 claims
- 0744US2022241263A1Pd-1 axis binding antagonist to treat cancer with genetic mutations in specific genesARES TRADING SA·Filed 2020·Application pending·0 cites
- 0841US2017240639A1Actrii antagonists for use in increasing immune activityACCELERON PHARMA INC·Filed 2017·Application pending·0 cites
- 0938US2017152490A9Use of activin receptor-like kinase 1 (alk-1) antagonists in the treatment of cancerACCELERON PHARMA INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →